Adaptimmune Therapeutics plc
Home
Our Company
Overview
arrow_forward
Partners
arrow_forward
Board of Directors
arrow_forward
Leadership Team
arrow_forward
Scientific Advisory Board
arrow_forward
Perspectives
arrow_forward
COVID-19
arrow_forward
Pipeline
Overview
arrow_forward
ADP-A2M4
arrow_forward
ADP-A2M4CD8
arrow_forward
ADP-A2AFP
arrow_forward
ADP-A2M10
arrow_forward
Technology
Overview
arrow_forward
Manufacturing
arrow_forward
Publications
arrow_forward
Patients & Families
Overview
arrow_forward
Taking Part in Our Clincial Trials
arrow_forward
Cancer Info
arrow_forward
Cancer Immunotherapy Month
arrow_forward
Videos
arrow_forward
Clinical Trials
Investors & Media
Overview
arrow_forward
News & Events
arrow_forward
Annual Shareholder Meeting
arrow_forward
Company Info
arrow_forward
Financial Info
arrow_forward
Stock Data
arrow_forward
SEC Filings
arrow_forward
Governance
arrow_forward
Media
arrow_forward
Contact
Careers
Overview
arrow_forward
U.S. Careers
arrow_forward
UK Careers
arrow_forward
Media
Investors & Media
Investors & Media
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Annual Shareholder Meeting
Company Info
Overview
Leadership Team
Board of Directors
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Media
Jan 5, 2018
Media Backgrounder
Email Alerts
Tear Sheet
Contacts
RSS News Feed
